Trial
NCT01253382
Study to Evaluate Ecallantide in Paediatric Patients With Acute Attacks of Hereditary Angioedema
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Shire
Collaborators
—
Condition
Hereditary Angioedema (HAE)
Intervention
ecallantide
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-05-18